Abstract
Gut-microbiota (GM) is considered a hidden metabolic organ of the human body, providing biochemical pathways which are absent in the host. Balanced diet with calorie restriction (CR) promotes growth of healthy microbiota, leading to longevity by down-regulating inflammatory responses. While, dysbiosis leads to body dysfunction, inducing metabolic disorders, causing poor epithelial architecture, and impeding the development of mucosal-associated lymphoid tissue, resulting in with reduced T and B cell populations, rendering the body prone to infections, cancer and allergy. The GM enzymes activity is a new risk factor for cancer while gut-derived interleukin-6 is associated with hepatocellular carcinoma development. GM can also influence the brain biochemistry and emotional behavior. The altered GM affects the genes involved in second messenger pathway and long-term potentiation, leading to their differential expression in the hippocampus, cortex, striatum and cerebellum. In addition, the dysbiotic GM is associated with autistic disorder. Living with dysbiotic GM is possible with consequences of serious impairments.
Keywords: Allergy, cancer, gut-microbiota, metabolism, immunity, heart diseases, nervous system.
CNS & Neurological Disorders - Drug Targets
Title:Implication of Gut Microbiota in Human Health
Volume: 13 Issue: 8
Author(s): Imran Khan, Muhammad Yasir, Esam I. Azhar, Taha Kumosani, Elie K. Barbour, Fehmida Bibi and Mohammad A. Kamal
Affiliation:
Keywords: Allergy, cancer, gut-microbiota, metabolism, immunity, heart diseases, nervous system.
Abstract: Gut-microbiota (GM) is considered a hidden metabolic organ of the human body, providing biochemical pathways which are absent in the host. Balanced diet with calorie restriction (CR) promotes growth of healthy microbiota, leading to longevity by down-regulating inflammatory responses. While, dysbiosis leads to body dysfunction, inducing metabolic disorders, causing poor epithelial architecture, and impeding the development of mucosal-associated lymphoid tissue, resulting in with reduced T and B cell populations, rendering the body prone to infections, cancer and allergy. The GM enzymes activity is a new risk factor for cancer while gut-derived interleukin-6 is associated with hepatocellular carcinoma development. GM can also influence the brain biochemistry and emotional behavior. The altered GM affects the genes involved in second messenger pathway and long-term potentiation, leading to their differential expression in the hippocampus, cortex, striatum and cerebellum. In addition, the dysbiotic GM is associated with autistic disorder. Living with dysbiotic GM is possible with consequences of serious impairments.
Export Options
About this article
Cite this article as:
Khan Imran, Yasir Muhammad, Azhar I. Esam, Kumosani Taha, Barbour K. Elie, Bibi Fehmida and Kamal A. Mohammad, Implication of Gut Microbiota in Human Health, CNS & Neurological Disorders - Drug Targets 2014; 13 (8) . https://dx.doi.org/10.2174/1871527313666141023153506
DOI https://dx.doi.org/10.2174/1871527313666141023153506 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Development on Anti-Obesity Compounds and their Mechanisms of Action: A Review
Current Medicinal Chemistry Current Genomics in Cardiovascular Medicine
Current Genomics Protective Effects of Terpenes on the Cardiovascular System: Current Advances and Future Perspectives
Current Medicinal Chemistry Therapeutic and Protective Potential of Mesenchymal Stem Cells, Pharmaceutical Agents and Current Vaccines Against COVID-19
Current Stem Cell Research & Therapy Humoral Immunity in Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets CD36 as a Multiple-Ligand Signaling Receptor in Atherothrombosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Post-traumatic Stress Disorder in Heart Failure Patients: A Test of the Cardiac Disease-induced PTSD Hypothesis
Current Psychiatry Research and Reviews Definitions of Metabolic Syndrome: Where are We Now?
Current Vascular Pharmacology Pharmaceutical Care: Past, Present and Future
Current Pharmaceutical Design Molecular Determinants of Vascular Calcification: A Bench to Bedside View
Current Molecular Medicine Electrochemical Sensors for Hydroperoxides Based on Prussian Blue
Current Analytical Chemistry Omega-3 Fatty Acids for Nutrition and Medicine: Considering Microalgae Oil as a Vegetarian Source of EPA and DHA
Current Diabetes Reviews Impact of Bread Made from Mix Cereals and Pulses on the Glycemic Profile in Type 2 Diabetic Patients - A Randomized Controlled Trial
Current Nutrition & Food Science Pharmacologic Approach to Heart Failure in Children
Current Cardiology Reviews Withdrawal Notice: The Recent Advancement in the Field of Super Paramagnetic Iron Oxide Nanoparticles (SPIONs) for Aiming Breast Cancer
Current Drug Metabolism Thrombolytic Therapy in Acute Ischemic Stroke - Basic Concepts
Current Vascular Pharmacology Protective Effect of Natural Antioxidants on Heart Against Ischemia-Reperfusion Damage
Current Pharmaceutical Biotechnology Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis
Current Pharmaceutical Design Current Problems, New Opportunities and Future Directions of Antiplatelet Therapy - Increasing Role of Novel Antiplatelet Agents in Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Drug Interactions between Non-Steroidal Anti-Inflammatory Drugs and Cardiovascular Treatments (Except Anti-Agregant Therapy)
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry